297 completed. 297 Phase 3, 47 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 297 | Completed 297 |
| Phase 2 | 47 | Completed 47 |
Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Single Arm, Open Study on vYF in Adults Yellow fever vaccine (live) - Yellow Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 254 | 2025-10-23 | 2026-02-03 |
| Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults Yellow fever vaccine (live), YF vaccine (live) - Yellow Fever Immunization | Phase 3 | Completed | Sanofi | 640 | 2025-05-22 | 2026-02-02 |
| A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan TDV, Placebo - Dengue Fever | Phase 2 / Phase 3 | Completed | Takeda | 187 | 2025-01-31 | 2025-12-30 |
| The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever Ribavirin, Standard Treatment - Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Completed | Khyber Medical University Peshawar | 284 | 2024-12-17 | 2025-06-26 |
| Parasite Clearance and Protection From Infection (PCPI) in Zambia SP (Macleods Pharmaceuticals Ltd), AS (Guilin Pharmaceuticals) - Malaria | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 600 | 2024-07-24 | 2025-03-12 |
| Parasite Clearance and Protection From Infection (PCPI) in Cameroon SP (Macleods Pharmaceuticals Ltd), SPAQ (Guilin Pharmaceuticals), AS (Guilin Pharmaceuticals) - Malaria | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 902 | 2024-06-10 | 2025-03-12 |
| Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria KLU156, Coartem - Uncomplicated Plasmodium Falciparum Malaria | Phase 3 | Completed | Novartis Pharmaceuticals | 1720 | 2024-03-07 | 2026-11-04 |
| Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial Carica Papaya Leaf Extract, Placebo - Dengue | Phase 3 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 250 | 2023-10-01 | 2026-06-16 |
| Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities Mesh - spatial repellent impregnated with transfluthrin (2500mg), Information and Education Campaigns (IEC), test and treat malaria cases - Malaria, Childhood ALL | Phase 3 | Completed | The Mentor Initiative | 2400 | 2023-06-05 | 2024-04-23 |
| A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL STAMARIL, SII-YFV - Yellow Fever | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1824 | 2023-05-11 | 2025-05-07 |
| Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial Artemether-lumefantrine and Amodiaquine Drug Combination, Artemether-lumefantrine then Artesunate amodiaquine, Artemether-lumefantrine - Uncomplicated Plasmodium Falciparum Malaria | Phase 2 / Phase 3 | Completed | Muhimbili University of Health and Allied Sciences | 384 | 2023-05-01 | 2026-09-23 |
| Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children VLA15, Normal Saline - Lyme Disease | Phase 3 | Completed | Pfizer | 3547 | 2022-12-12 | 2026-05-07 |
| Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan drug: miltefosine with thermotherapy - Old World Cutaneous Leishmaniasis | Phase 3 | Completed | Medecins Sans Frontieres, Netherlands | 645 | 2022-10-07 | 2026-07-30 |
| An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) VLA15, Saline - Lyme Disease | Phase 3 | Completed | Pfizer | 12546 | 2022-08-04 | 2026-06-04 |
| Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients Acoziborole - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 35 | 2022-07-09 | 2026-04-06 |
| Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years CHIKV VLP/adjuvant, Placebo - Chikungunya Virus | Phase 3 | Completed | Bavarian Nordic | 413 | 2022-05-12 | 2024-12-13 |
| Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) Albendazole Pill, Ivermectin Pill, Ivermectin Injectable Product - Malaria | Phase 3 | Completed | Barcelona Institute for Global Health | 48145 | 2022-03-17 | 2025-03-14 |
| A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents Active, Placebo - Chikungunya | Phase 3 | Completed | Butantan Institute | 754 | 2022-02-14 | 2026-06-04 |
| Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects Acoziborole, Placebo - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 1208 | 2021-12-30 | 2025-03-20 |
| A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) CHIKV VLP/adjuvant, Placebo - Chikungunya Virus | Phase 3 | Completed | Bavarian Nordic | 3258 | 2021-09-29 | 2024-08-30 |
Showing 20 of 297. Sign in to see all of them.
Malaria (133) · Malaria, Falciparum (47) · Encephalitis, Japanese (30) · Dengue (18) · Leishmaniasis, Cutaneous (14) · Malaria, Vivax (14) · Leishmaniasis, Visceral (13) · Severe Dengue (10) · Encephalitis, Tick-Borne (9) · Anemia (8) · Schistosomiasis (8) · Trypanosomiasis, African (7) · Chagas Disease (6) · Elephantiasis, Filarial (6) · HIV Infections (6)
Infections (292) · Mosquito-Borne Diseases (222) · Parasitic Diseases (216) · Protozoan Infections (199) · Virus Diseases (77) · RNA Virus Infections (76) · Arbovirus Infections (67) · Flaviviridae Infections (62) · Flavivirus Infections (61) · Central Nervous System Diseases (43) · Central Nervous System Infections (43) · Euglenozoa Infections (42) · Nervous System Diseases (42) · Neuroinflammatory Diseases (40)
Artemether, Lumefantrine Drug Combination (33) · fanasil, pyrimethamine drug combination (31) · Chloroquine (22) · Artesunate (18) · Amodiaquine (16) · Primaquine (16) · Azithromycin (11) · amodiaquine, artesunate drug combination (11) · miltefosine (11) · Paromomycin (10) · Praziquantel (10) · pyronaridine tetraphosphate, artesunate drug combination (9) · Doxycycline (8) · Ivermectin (8) · Mefloquine (7)
London School of Hygiene and Tropical Medicine (43) · Sanofi Pasteur, a Sanofi Company (16) · Drugs for Neglected Diseases (14) · Pfizer (14) · University of Oxford (13) · Valneva Austria GmbH (13) · GlaxoSmithKline (10) · University of California, San Francisco (9) · Institute of Tropical Medicine, Belgium (8) · Takeda (7) · Sanofi (6) · Liverpool School of Tropical Medicine (5) · Medicines for Malaria Venture (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Menzies School of Health Research (4)
Kenya (29) · Burkina Faso (28) · Uganda (27) · United States (23) · Ghana (18) · Mali (16) · Tanzania (16) · Democratic Republic of the Congo (15) · Brazil (14) · Thailand (14) · The Gambia (12) · India (11) · Colombia (9) · Mozambique (9) · Nigeria (9)
Grant Dorsey, MD, PhD (6) · Diane V Havlir, MD (4) · Astrid Kaltenboeck, Ph.D. (3) · Brian Greenwood, FRCP, FRS (3) · Brian Greenwood, MD (3) · Eric Ottesen, MD (3) · Jayaram Menon, MBBS (3) · Paul J Milligan, PhD (3) · Shyam Sundar, MD (3) · Tsin Yeo, MBBS (3) · Alassane Dicko, Professor (2)
PMID 40099800, PMID 23433102, PMID 26666916, PMID 39324693, PMID 11873261, PMID 22610930, PMID 32228663, PMID 10656038, PMID 20934459, PMID 21849081, PMID 22993389, PMID 25425434, PMID 26214039, PMID 27007959, PMID 27418050, PMID 27459266, PMID 28871961, PMID 29300876, PMID 29547881, PMID 29897841, PMID 33020153, PMID 33212068, PMID 33822015, PMID 34003796, PMID 34219653, PMID 35659904, PMID 35709798, PMID 35732155, PMID 36534705, PMID 8937280, PMID 9790423, PMID 12510893, PMID 16235350, PMID 16503464, PMID 16551365, PMID 16640611, PMID 16702588, PMID 16837678, PMID 17046467, PMID 17239256, PMID 17519409, PMID 17519410, PMID 17582067, PMID 17940319, PMID 17971864, PMID 18074034, PMID 18171245, PMID 18213379, PMID 18237394, PMID 18394765
2008 (2), 2014 (2), 2019 (2), 2023 (2), P01HD059454 (2), 2009 (1), 2015 (1), 2016 (1), 2018 (1), 2025 (1), P60AR036308 (1), R01AI031561 (1), R01AI104702 (1), U01AI126610 (1), U01AI138910 (1)